SCHOTT Pharma
Francesco Bigolin is a Business Development Specialist at SCHOTT Pharma, having transitioned through roles as a Business Developer (Working Student) and Intern in Business Development Sterile Solutions. Additionally, Francesco serves as a Student Consultant at go-climate AG until December 2024 and previously completed an internship at BBM Officine Meccaniche SpA. Francesco's academic journey includes a current pursuit of a Master of Marketing Management at the University of St.Gallen, following a Master's degree in Accounting and Finance and a Bachelor's degree in Business Administration from the same institution. Additional qualifications include a Cambridge C1 English certification obtained at EF Language Abroad.
This person is not in any teams
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social